Literature DB >> 6774044

HLA-DR antigens have polymorphic light chains and invariant heavy chains as assessed by lysine-containing tryptic peptide analysis.

J F Kaufman, R L Andersen, J L Strominger.   

Abstract

HLA-DR antigens were isolated from B lymphoblastoid cells labeled with either [3H]- or [14C]lysine. Double-label comparisons of the tryptic peptides by microbore ion-exchange chromatography led to the following conclusions: The heavy and light chains share few peptides, one of which is free lysine that is liberated from the polypeptide chains by trypsin. The heavy chains of different HLA-DR allospecificities are virtually identical in all cell lines examined. In contrast, the light chains of different HLA-DR allospecificities are nonidentical and, thus, must bear the alloantigenic determinant.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6774044

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  Polymorphisms within the HLA-DRw6 haplotype. II. Protein charge heterogeneity reflects MLC subtyping of HLA-DRw6 homozygous cells.

Authors:  M L Bosch; A Termijtelen; R Gerrets; G M Schreuder; R E Bontrop; M J Giphart
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

2.  Analysis of the DR beta chains from two DRw6 cell lines (WT46 and WT52): recombination in vivo may have generated new haplotypes.

Authors:  P J Knudsen; J McLean; J L Strominger
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

3.  Polymorphisms within the HLA-DR3 haplotypes. I. HLA-DR polymorphisms detected at the protein and DNA levels are reflected by T-cell recognition.

Authors:  R Bontrop; M Tilanus; M Mikulski; M van Eggermond; A Termijtelen; M Giphart
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

4.  The alpha chain, not the beta chain of HLA-DR antigens participates in activation of T cells in autologous mixed lymphocyte reaction.

Authors:  R Palacios; L Claesson; G Möller; P A Peterson; E Möller
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

5.  Mapping of the genes encoding the HLA-DR alpha chain and the HLA-related antigens to a chromosome 6 deletion by using genomic blotting.

Authors:  H A Erlich; D Stetler; R Saiki; P Gladstone; D Pious
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

6.  Expression of T-lymphoblast-encoded HLA-DR antigens on human T-B lymphoblast hybrids.

Authors:  D N Howell; P Cresswell
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

7.  Control of HLA-DR antigen gene expression at the pretranslational level: comparison of an HLA-DR-positive B lymphoblastoid cell line and its HLA-DR-negative variant.

Authors:  S Loosmore; P Gladstone; D Pious; L M Jerry; T Tamaoki
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

8.  Role of individual chains of HLA-DR antigens in activation of T cells induced by alloantigens.

Authors:  R Palacios
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

9.  HLA-DR antigens induce proliferation and cytotoxicity of T cells against haptenated (TNP and FITC) self structures.

Authors:  R Palacios; G Möller; L Claesson; P A Peterson
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

10.  Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen.

Authors:  D A Shackelford; D L Mann; J J van Rood; G B Ferrara; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.